LARIMAR

LIVE

Serial Number

88446118

Owner

Larimar Therapeutics, Inc.

Attorney

Keith Toms, Esq.

Filing Date

May 24, 2019

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

LARIMAR Trademark

Serial Number: 88446118 • Registration: 6980603

LARIMAR is a trademark filed by Larimar Therapeutics, Inc. on May 24, 2019. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Class 42 - Computer & Scientific

Scientific and technological services; industrial analysis and research services

Owner Contact Info

Larimar Therapeutics, Inc. (7 trademarks)

Three Bala Plaza East, Suite 506
Bala Cynwyd, PA 19004

Entity Type: 03

Chondrial Therapeutics Inc. (4 trademarks)

Bala Cynwyd, PA 19004

Entity Type: 03

Legal Representation

Attorney of Record

Keith Toms, Esq.

1,279 trademarks filed View all →

Trademark Details

Filing Date

May 24, 2019

Registration Date

February 14, 2023

Published for Opposition

October 22, 2019

Goods & Services

Pharmaceutical preparations for the treatment of mitochondrial disorders; Pharmaceutical preparations and substances for treatment of genetic diseases; pharmaceutical preparations for the treatment of diseases or dysfunction of the mitochondria; pharmaceutical preparations featuring cell penetrating peptides for use in the treatment of genetic disorders; pharmaceuticals that treat genetic diseases by use of carrier proteins; pharmaceutical preparations for the treatment of ataxia; pharmaceutical preparations for the treatment of Friedreich's Ataxia; pharmaceutical preparations for protein replacement therapy

Pharmaceutical research and development; research and development in the pharmaceutical and biotechnology fields; research in the field of pharmaceuticals and drugs; conducting genomic analysis, pre-clinical studies and clinical trials for others in the field of pharmaceutical preparations for treatment of diseases

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Feb 14, 2023 NRCC

REGISTERED-PRINCIPAL REGISTER

Feb 14, 2023 R.PR

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Jan 7, 2023 SUNA

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Jan 6, 2023 CNPR

STATEMENT OF USE PROCESSING COMPLETE

Dec 16, 2022 SUPC

USE AMENDMENT FILED

Dec 13, 2022 IUAF

TEAS STATEMENT OF USE RECEIVED

Dec 13, 2022 EISU

ASSIGNED TO EXAMINER

Dec 13, 2022 DOCK

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Aug 31, 2022 EXRA

SOU EXTENSION 5 GRANTED

Aug 30, 2022 EX5G

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Aug 29, 2022 AITU

SOU EXTENSION 5 FILED

Jun 9, 2022 EXT5

SOU TEAS EXTENSION RECEIVED

Jun 9, 2022 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Dec 18, 2021 EXRA

SOU EXTENSION 4 GRANTED

Dec 16, 2021 EX4G

SOU EXTENSION 4 FILED

Dec 16, 2021 EXT4

SOU TEAS EXTENSION RECEIVED

Dec 16, 2021 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jun 22, 2021 EXRA

SOU EXTENSION 3 GRANTED

Jun 21, 2021 EX3G

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

Jun 16, 2021 ASGN

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Jun 14, 2021 AITU

SOU EXTENSION 3 FILED

Jun 7, 2021 EXT3

SOU TEAS EXTENSION RECEIVED

Jun 7, 2021 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Dec 3, 2020 EXRA

SOU EXTENSION 2 GRANTED

Dec 1, 2020 EX2G

SOU EXTENSION 2 FILED

Dec 1, 2020 EXT2

SOU TEAS EXTENSION RECEIVED

Dec 1, 2020 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Apr 28, 2020 EXRA

SOU EXTENSION 1 GRANTED

Apr 24, 2020 EX1G

SOU EXTENSION 1 FILED

Apr 24, 2020 EXT1

SOU TEAS EXTENSION RECEIVED

Apr 24, 2020 EEXT

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Dec 17, 2019 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Oct 22, 2019 NPUB

PUBLISHED FOR OPPOSITION

Oct 22, 2019 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Oct 2, 2019 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Sep 17, 2019 CNSA

EXAMINER'S AMENDMENT ENTERED

Sep 17, 2019 XAEC

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Sep 17, 2019 GNEN

EXAMINERS AMENDMENT E-MAILED

Sep 17, 2019 GNEA

EXAMINERS AMENDMENT -WRITTEN

Sep 17, 2019 CNEA

NOTIFICATION OF PRIORITY ACTION E-MAILED

Aug 20, 2019 GPRN

PRIORITY ACTION E-MAILED

Aug 20, 2019 GPRA

PRIORITY ACTION WRITTEN

Aug 20, 2019 CPRA

ASSIGNED TO EXAMINER

Aug 13, 2019 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jun 10, 2019 NWOS

NEW APPLICATION ENTERED

May 28, 2019 NWAP

Related Trademarks

More from this Owner

More in Same Class

RAPIDRI

TAC PAC

INTRATUS

DCNHC

Serial #79262730

EARTH ECHO